retatrutide safety trial results Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a How long does retatrutide last:

The pathophysiology of HS is complex but involves follicular hyperkeratosis/occlusion, sweat gland dysfunction, immune dysregulation, bacterial infections, and chronic local and systemic inflammation

Some patients may eventually transition to lower maintenance doses after reaching their weight goal, though complete discontinuation typically leads to gradual weight regain

Oesterle TS, Ho M-F

Efficacy of polyphenolic compounds for hair regeneration: a systematic review and meta-analysis

Does retatrutide cause hair loss like some people report on tirzepatide

There is no completed head-to-head trial proving one is superior in the same population